Kent Imaging
Share
Bacterial burden in chronic wounds isn't always visible but it's always relevant.
SnapshotGLO uses bacterial autofluorescence imaging to detect bacteria at the point of care, helping clinicians make faster, more targeted treatment decisions for DFUs, VLUs, and other complex chronic wounds.
05/14/2026
Kent Imaging and Roots Pharmaceutical Announce Distribution Agreement to Bring SnapshotNIR to the GCC and Iraq
“Expansion into this region represents a tremendous opportunity to bring meaningful change to patients living with complex wounds, vascular disease, and diabetic complications,” said Pierre Lemire, Chief Executive Officer of Kent Imaging.
Dr. Islam Zayed, CEO of Roots Pharmaceutical commented, “SnapshotNIR directly addresses that need, and its introduction reinforces our commitment to bringing the most clinically meaningful innovations to the region. We are excited to be partnering with Kent Imaging and look forward to making SnapshotNIR widely accessible across our markets.”
Read the full press release: https://hubs.la/Q04gHNwV0
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
Suite 300, 1210 8 Street SW
Calgary, AB
T2R1L3
